Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Randomized Controlled Study on Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient-reported outcomes (PROs) in enhancing postoperative care and survival rates through improved symptom monitoring and patient engagement. Utilizing internet technology, specifically a platform integrated with WeChat, the study aims to improve patient management and follow-ups post-discharge. The objective is to use mobile internet technology to build a high-quality prospective database on postoperative lung cancer patient outcomes, analyzing factors affecting postoperative discomfort and assessing the role of interactive platforms in improving patient care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Diagnosed with Stage I-III lung cancer and surgically resected at our centre.

• Owns and uses a smartphone and can use WeChat.

• Volunteer to participate in this study and sign an informed consent form.

Locations
Other Locations
China
Zuodong Song
RECRUITING
Shanghai
Contact Information
Primary
Xinghua Cheng, MD
chengxinghua_001@163.com
+8617701681215
Backup
Xinghua Cheng
chengxinghua_001@163.com
+8617701681215
Time Frame
Start Date: 2024-03-24
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 216
Treatments
Experimental: Group A
Mobile Internet Platform Follow-up Group
No_intervention: Group B
Traditional Outpatient Follow-up Group
Related Therapeutic Areas
Sponsors
Leads: Shanghai Chest Hospital

This content was sourced from clinicaltrials.gov